A drug with the SMILES CC1(c2ccc(Cl)cc2Cl)NC(=O)N(CC(=O)Nc2ccc3[nH]c(=O)[nH]c3c2)C1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 5.838%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CC1(c2ccc(Cl)cc2Cl)NC(=O)N(CC(=O)Nc2ccc3[nH]c(=O)[nH]c3c2)C1=O
CC1(c2ccc(Cl)cc2Cl)NC(=O)N(CC(=O)Nc2ccc3[nH]c(=O)[nH]c3c2)C1=O
2-[4-(2,4-dichlorophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)acetamide